Edgestream Partners L.P. Purchases New Shares in Bath & Body Works, Inc. $BBWI

Edgestream Partners L.P. acquired a new position in Bath & Body Works, Inc. (NYSE:BBWI – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 162,408 shares of the company’s stock, valued at approximately $2,586,000.

Other hedge funds have also modified their holdings of the company. Elevation Wealth Partners LLC increased its position in Bath & Body Works by 5,278.8% in the second quarter. Elevation Wealth Partners LLC now owns 1,775 shares of the company’s stock worth $41,000 after purchasing an additional 1,742 shares during the last quarter. Parallel Advisors LLC raised its stake in Bath & Body Works by 35.5% during the first quarter. Parallel Advisors LLC now owns 2,570 shares of the company’s stock valued at $48,000 after purchasing an additional 673 shares in the last quarter. Meeder Asset Management Inc. purchased a new stake in Bath & Body Works during the second quarter valued at $66,000. Global Retirement Partners LLC bought a new position in Bath & Body Works during the second quarter valued at $71,000. Finally, Mirae Asset Global Investments Co. Ltd. bought a new position in Bath & Body Works during the third quarter valued at $72,000. 95.14% of the stock is owned by hedge funds and other institutional investors.

Latest Bath & Body Works News

These are some of the BBWI news items that stood out recently:

  • Neutral Sentiment: A limited-edition holiday fragrance collection with Pantone adds a product and gifting initiative, though its near-term financial impact is unclear. Bath & Body Works and Pantone holiday collection
  • Negative Sentiment: Q4 EPS guidance of $1.41–$1.61 came in below the $1.72 analyst consensus, with revenue guidance also below expectations at the midpoint. Reports of softer expected holiday sales add to concerns about near-term demand. Bath & Body Works trims FY26 EPS outlook
  • Negative Sentiment: Several firms lowered their BBWI price targets after the results, including UBS ($22 to $19), BMO ($24 to $20), and JPMorgan ($24 to $23). Most maintained neutral or equivalent ratings, signaling caution despite targets generally remaining above the recent share price. UBS Group rating and price target

Wall Street Analysts Forecast Growth

A number of brokerages have commented on BBWI. Argus reissued a “hold” rating on shares of Bath & Body Works in a research note on Wednesday, September 16th. JPMorgan Chase & Co. decreased their target price on shares of Bath & Body Works from $24.00 to $23.00 and set a “neutral” rating on the stock in a research report on Friday. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bath & Body Works in a report on Tuesday, October 6th. Robert W. Baird lowered their price target on shares of Bath & Body Works from $23.00 to $22.00 and set a “neutral” rating for the company in a report on Friday. Finally, Bank of America dropped their price target on Bath & Body Works from $30.00 to $25.00 and set a “buy” rating for the company in a research report on Friday. Four research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $22.00.

Check Out Our Latest Analysis on BBWI

Bath & Body Works Stock Performance

NYSE:BBWI opened at $18.67 on Friday. The stock’s fifty day moving average is $19.24 and its 200 day moving average is $19.75. Bath & Body Works, Inc. has a fifty-two week low of $14.27 and a fifty-two week high of $24.94. The firm has a market capitalization of $3.76 billion, a PE ratio of 5.10, a PEG ratio of 0.97 and a beta of 1.31.

Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its quarterly earnings results on Thursday, November 19th. The company reported $0.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.12 by $0.14. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.55 billion. Bath & Body Works had a negative return on equity of 53.48% and a net margin of 10.83%. Bath & Body Works’s revenue was down 1.1% on a year-over-year basis. During the same period last year, the company earned $0.37 earnings per share. Bath & Body Works has set its Q4 2026 guidance at 1.410-1.610 EPS and its FY 2026 guidance at 2.600-2.800 EPS. Equities analysts forecast that Bath & Body Works, Inc. will post 2.77 EPS for the current year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 4th. Stockholders of record on Friday, November 20th will be paid a $0.20 dividend. The ex-dividend date of this dividend is Friday, November 20th. This represents a $0.80 annualized dividend and a dividend yield of 4.3%. Bath & Body Works’s dividend payout ratio is currently 20.83%.

Bath & Body Works Company Profile

(Free Report)

Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.

Further Reading

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.